Webinar | Cardiovascular Ultrasound| August 27, 2021

Sponsored by Siemens and Epsilon Imaging

Siemens now seamlessly integrates Epsilon Imaging's strain echo software.

This educational webinar is focused on the value echocardiographic strain imaging brings to a contemporary cardiology practice presented by Anya Narezkina, M.D. She is an assistant clinical professor, Division of Cardiovascular Medicine and director of the Cardio-Oncology Program at the University of California San Diego Cardiovascular Institute. 

The webinar takes place Sept. 21, at 3 p.m. eastern time / 2 p.m. central time.

The webinar will cover the importance of myocardial strain imaging and current guidelines recommended by the American Society of Echocardiography (ASE). Additionally, it will focus on the development of a comprehensive cardio-oncology program and the utility of strain imaging for diagnostic and surveillance for cardiotoxicity as well as other clinical indications. The webinar will conclude with a look into the future of strain imaging for echocardiography, followed by a Q & A session.

Register for this Webinar

Learning Objectives:

• Staying abreast of the current guidelines on strain imaging
• Understanding the utility of echo strain assessment in clinical practice
• Proper utilization of strain applications in cardio-oncology
• Understanding the value of strain imaging for prognostication in the clinical setting

Speaker Profile:

Anya Narezkina, M.D. Assistant Clinical Professor, Division of Cardiovascular Medicine Director of the Cardio-Oncology Program University of California San Diego Cardiovascular InstituteAnya Narezkina, M.D.
Assistant Clinical Professor, Division of Cardiovascular Medicine
Director of the Cardio-Oncology Program
University of California San Diego Cardiovascular Institute

Narezkina is a board-certified cardiologist who specializes in cardio-oncology. As director of the cardio-oncology program at UC San Diego Health, She works in close collaboration with oncologists to address the heart needs of patients undergoing chemotherapy, targeted cancer therapy, immunotherapy, radiation therapy or bone marrow transplantation. Her research has focused on understanding risks of cardiac complications with cancer therapies.

Narezkina also collaborates with bioengineering department at UC San Diego on developing novel imaging approaches for early diagnosis of cardiotoxicity in patients treated with chemotherapy. 

She completed a fellowship in cardiology and a residency in internal medicine and at UC San Diego School of Medicine. She earned her medical degree from the Smolensk State Medical Academy in Russia. She is board certified in internal medicine and cardiovascular disease. Narezkina is also certified by the National Board of Echocardiography in adult comprehensive echocardiography.

Company Profiles:

Epsilon Imaging
Epsilon Imaging is a provider of workflow enhancing solutions for cardiology based in Ann Arbor, Michigan, USA, and is transforming cardiac diagnostic workflow with a vendor neutral suite of software applications designed for echocardiography. EchoInsight provides a suite of clinical applications that provide visualization and analysis with practical strain imaging for the clinical environment. Applications assist clinicians to improve, standardize, and streamline interpretation and reporting of echo studies. Clinical applications include LV, LV Contrast, RV, Full Heart and Stress Echo.

Siemens Healthineers
At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey toward expanding precision medicine, transforming care delivery, and improving patient experience, all made possible by digitalizing healthcare. An estimated 5 million patients globally benefit every day from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics, and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 120 years of experience and 18,500 patents globally. Through the dedication of more than 50,000 dedicated colleagues in 70 countries, we will continue to innovate and shape the future of healthcare.

Register for this Webinar

Related Content

News | Cardio-oncology

February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMCC) ...

Home February 25, 2021
Home
News | Cardio-oncology

July 29, 2019 — Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest ...

Home July 29, 2019
Home
Videos | Cardio-oncology

Magid Awadalla, MBBS, is an advanced cardiac imaging research fellow at Massachusetts General Hospital. He has been ...

Home March 22, 2019
Home
News | Cardio-oncology

March 13, 2019 — An imaging procedure commonly performed before starting cancer treatment can provide valuable clues ...

Home March 13, 2019
Home
News | Cardio-oncology

January 28, 2019 — The American College of Cardiology host the third Advancing the Cardiovascular Care of the Oncology ...

Home January 28, 2019
Home
News | Cardio-oncology

January 3, 2019 — Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage ...

Home January 03, 2019
Home
News | Cardio-oncology

December 21, 2018 — Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to ...

Home December 21, 2018
Home
News | Cardio-oncology

December 7, 2018 — New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE ...

Home December 07, 2018
Home
News | Cardio-oncology

August 7, 2018 — While heart failure is an uncommon complication of breast cancer treatment, the risk is higher in ...

Home August 07, 2018
Home
News | Cardio-oncology

March 14, 2018 — After six months of follow-up, women newly diagnosed with breast cancer who were given the beta blocker ...

Home March 14, 2018
Home
Subscribe Now